RossMNesbitMD
Nephrology • Knoxville, TNAcute Renal Failure, Chronic Renal Failure & Dialysis, Glomerular Disease
Asst Professor of Medicine
Dr. Nesbit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1932 Alcoa Hwy
Suite C 460
Knoxville, TN 37920Phone+1 865-546-9246Fax+1 865-523-6466
Education & Training
Vanderbilt University Medical CenterFellowship, Nephrology, 2012 - 2014
Carolinas Medical CenterResidency, Internal Medicine, 2009 - 2012
University of South Carolina School of MedicineClass of 2009
Certifications & Licensure
TN State Medical License 2014 - 2025
NC State Medical License 2009 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 67 citationsSafety Outcomes of Apixaban Compared With Warfarin in Patients With End-Stage Renal Disease:Stefanie C Sarratt, Ross Nesbit, Robert A Moye
The Annals of Pharmacotherapy. 2017-02-01 - 7 citationsVancomycin-Associated Acute Kidney Injury with a Steep Rise in Serum Creatinine.Juan Carlos Q. Velez, Ndidiamaka O. Obadan, Amit Kaushal, Mohammed Alzubaidi, Bhavna Bhasin
Nephron. 2018-01-01 - 2 citationsSafety outcomes of apixaban in patients with nonvalvular atrial fibrillation and severe renal impairmentMaura J Jones, Sarah T Eudaley, Robert A Moye, Terry A Hodge, Ross M Nesbit
Journal of Thrombosis and Thrombolysis. 2020-01-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
